Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT and 5FU/Capecitabine With or Without Zoledronic Acid in Locally Advanced Pancreatic Cancer
NCT03073785Phase 2Active, not recruiting
- Sponsor
- University of Nebraska
- Start
- Mar 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in pancreatic adenocarcinoma (PDAC), sponsored by University of Nebraska. Started Mar 2017; status: active, not recruiting.
02
Drugs
zoledronic acid
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT03073785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073785.